TY - JOUR T1 - Difference of brain cortical thickness and area of different lobes between fetuses with intrauterine growth restriction and control group assessed by 3 Tesla MRI JF - medRxiv DO - 10.1101/2020.10.31.20222737 SP - 2020.10.31.20222737 AU - Behnaz Moradi AU - Mahboobeh Shirazi AU - Zohreh Alibeigi nezhad AU - Nazanin Seyed Saadat AU - Hassan Hashemi AU - Mohammad Ali Kazemi AU - Masoumeh Gity AU - Maryam Rahmani AU - Hossein Ghanaati Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20222737.abstract N2 - Background Intrauterine growth restricted (IUGR) is a major factor of perinatal and long-term morbidity and is associated with abnormal fetal brain development but its pattern of brain involvement is still unknown.Materials and Methods 42 women with IUGR pregnancy and 28 women with normally-grown fetuses between 28-38 weeks underwent 3Tesla MRI. Cortical thickness was assessed in 4 regions and was corrected by biparietal diameter/2. Also, whole brain surface area (WBA) and areas of 6 brain regions were included and corrected by WBA.Results IUGR fetuses had significantly thinner cortical thickness in the insula and temporal lobes compared to the control group (0.034 vs 0.043 and 0.036 vs 0.047 respectively, P value of < 0.05). They had significantly reduced WBA (P value: 0.028). The corrected brain areas were not significantly different between groups except for the corrected areas of cerebellum and hippocampus which were increased in IUGR fetuses compared to the control group (0.147vs 0.130,0.017vs 0.0125 respectively, P value of < 0.05).Conclusion IUGR fetuses had significantly thinner insular and temporal lobe cortex and smaller WBA compared to the control group. Among different brain regions, cerebellum and hippocampus were less affected by growth restriction in utero period.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNOAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the study was approved by our institutional board members in Tehran university of medical sciences with ethic approval code: IR.TUMS.MEDICINE.REC.1398.831All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTHE DATA ARE AVAILABLE ER -